NYSE · Healthcare

STEVANATO GROUP S P A STVN

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Medical Instruments & Supplies

Company profile

Business mix

  • It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
  • It also provides contract development and manufacturing services for customer-owned drug delivery devices.
  • The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers.
  • The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within medical instruments & supplies?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 1 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 31.39 FCF 0.05% Buyback -0.04%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Baron Capital Ron Baron 0.1% $34.4M 2026-03-31

Recent trading changes over the last 1 quarters

Net buyers 1 Last 1 13F filing periods
Net reducers 0 Last 1 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $6.9M Estimated from net added shares
Reduction amount $0 Estimated from net reduced shares
Net share change / base shares +24.9% +498,714 / 2,001,724
Baron Capital Ron Baron 1 filing periods
13F 2026-03-31 Filed 2026-05-15
Major increase Shares 24.9% 13F value change -$5.9M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 2,001,724 Last 1 periods +498,714 (+24.9%) Total shares 2,500,438 Value $34.4M

Recent mentions

No public mentions.